Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Collegium Pharmaceutical, Inc. (COLL : NSDQ)
 
 • Company Description   
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Number of Employees: 423

 
 • Price / Volume Information   
Yesterday's Closing Price: $23.53 Daily Weekly Monthly
20 Day Moving Average: 852,772 shares
Shares Outstanding: 32.56 (millions)
Market Capitalization: $766.03 (millions)
Beta: 0.72
52 Week High: $50.79
52 Week Low: $23.19
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -13.49% -13.11%
12 Week -31.18% -32.64%
Year To Date -49.18% -54.93%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 Technology Center Drive
-
Stoughton,MA 02072
USA		 ph: 781-713-3699
fax: -		 ir@collegiumpharma.com http://www.collegiumpharma.com
 
 • General Corporate Information   
Officers
Vikram Karnani - Chief Executive Officer and President
Gino Santini - Chairman
Colleen Tupper - Executive Vice President and Chief Financial Offic
Rita Balice-Gordon - Director
Garen G. Bohlin - Director

Peer Information
Collegium Pharmaceutical, Inc. (GSAC)
Collegium Pharmaceutical, Inc. (CASIF)
Collegium Pharmaceutical, Inc. (ALCD.)
Collegium Pharmaceutical, Inc. (OMNN)
Collegium Pharmaceutical, Inc. (CGPI.)
Collegium Pharmaceutical, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 19459J104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/05/26
Share - Related Items
Shares Outstanding: 32.56
Most Recent Split Date: (:1)
Beta: 0.72
Market Capitalization: $766.03 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.58 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $6.51 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 3.62
Trailing 12 Months: 3.37
PEG Ratio: -
Price Ratios
Price/Book: 2.45
Price/Cash Flow: 1.55
Price / Sales: 0.95
EPS Growth
vs. Year Ago Period: 6.80%
vs. Previous Quarter: 4.67%
Sales Growth
vs. Year Ago Period: 6.32%
vs. Previous Quarter: 3.29%
ROE
06/30/26 - 91.43
03/31/26 - 95.18
12/31/25 - 98.65
ROA
06/30/26 - 15.57
03/31/26 - 16.39
12/31/25 - 15.86
Current Ratio
06/30/26 - 1.03
03/31/26 - 1.71
12/31/25 - 1.57
Quick Ratio
06/30/26 - 0.84
03/31/26 - 1.62
12/31/25 - 1.48
Operating Margin
06/30/26 - 33.96
03/31/26 - 33.50
12/31/25 - 32.96
Net Margin
06/30/26 - 5.93
03/31/26 - 9.41
12/31/25 - 8.05
Pre-Tax Margin
06/30/26 - 9.61
03/31/26 - 13.59
12/31/25 - 11.87
Book Value
06/30/26 - 9.62
03/31/26 - 9.64
12/31/25 - 9.54
Inventory Turnover
06/30/26 - 5.50
03/31/26 - 7.84
12/31/25 - 8.22
Debt-to-Equity
06/30/26 - 3.32
03/31/26 - 2.47
12/31/25 - 2.59
Debt-to-Capital
06/30/26 - 76.87
03/31/26 - 71.14
12/31/25 - 72.12
 

Powered by Zacks Investment Research ©